Genzyme’s multiple sclerosis treatment approved by European Commission

New Drug Approvals

Alemtuzumab
Sanofi and its subsidiary Genzyme have been given marketing approval by the European Commission for Lemtrada (alemtuzumab), a treatment for multiple sclerosis.  read all at

click on title below

Genzyme’s multiple sclerosis treatment approved by European Commission

http://www.pharmaceutical-technology.com/news/newsgenzymes-multiple-sclerosis-treatment-approved-by-european-commission?WT.mc_id=DN_News

View original post

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s